20.61
Enliven Therapeutics Inc (ELVN) 最新ニュース
Enliven Therapeutics Inc. recovery potential after sell offOptions Play & Long-Term Capital Growth Ideas - newser.com
Is Enliven Therapeutics Inc. stock a safe haven assetPortfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
Why Enliven Therapeutics Inc. stock appeals to dividend seekers2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Real time breakdown of Enliven Therapeutics Inc. stock performanceEntry Point & AI Forecasted Entry/Exit Points - newser.com
Applying sector rotation models to Enliven Therapeutics Inc.Weekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Is Enliven Therapeutics Inc. stock cheap compared to fundamentals2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Is Enliven Therapeutics Inc. stock positioned well for digital economyJuly 2025 Volume & AI Optimized Trade Strategies - newser.com
Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 100% Upside Potential for Biotech Investors - DirectorsTalk Interviews
Assessing Enliven Therapeutics (ELVN) Valuation as Shares Show Signs of Short-Term Momentum - Yahoo Finance
Enliven Therapeutics Insider Sold Shares Worth $276,025, According to a Recent SEC Filing - MarketScreener
Published on: 2025-10-23 01:40:18 - newser.com
Lyssikatos, chief scientific officer, sells Enliven Therapeutics shares By Investing.com - Investing.com Canada
Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) Price Target at $41.20 - Defense World
Enliven Therapeutics CEO Kintz sells $266k in shares By Investing.com - Investing.com UK
ELVN insider sale: 12,500 shares sold; 902,892 shares remain held - Stock Titan
Is now a turning point for Enliven Therapeutics Inc.Global Markets & Risk Controlled Daily Plans - newser.com
Strategies to average down on Enliven Therapeutics Inc.Quarterly Profit Review & AI Powered Market Trend Analysis - newser.com
How to read the order book for Enliven Therapeutics Inc.2025 Institutional Moves & Verified Entry Point Signals - newser.com
Automated trading signals detected on Enliven Therapeutics Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Trading Recap: Why retail investors favor Enliven Therapeutics Inc. stockEarnings Overview Summary & Verified Momentum Stock Watchlist - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock rally after Fed decisions2025 Key Lessons & Real-Time Chart Pattern Alerts - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock split again soon2025 Market WrapUp & Reliable Breakout Forecasts - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock outperform tech sector in 2025July 2025 Institutional & Pattern Based Trade Signal System - nchmf.gov.vn
Heatmap analysis for Enliven Therapeutics Inc. and competitorsWatch List & Target Return Focused Picks - newser.com
Why retail investors favor Enliven Therapeutics Inc. stockWeekly Loss Report & Daily Profit Focused Screening - nchmf.gov.vn
Will Enliven Therapeutics Inc. stock continue dividend increases2025 Performance Recap & Daily Entry Point Trade Alerts - nchmf.gov.vn
(ELVN) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Investor Outlook on a Potential 89.66% Upside - DirectorsTalk Interviews
大文字化:
|
ボリューム (24 時間):